The efficacy and safety of sildenafil on treatment of patients with erectile dysfunction referred for posterior urethroplasty:a Single Center Experience

Qiang Fu,Xianjun Sun,Chenye Tang,Renjie Cui,Lei Chen,Yuemin Xu

DOI: https://doi.org/10.3969/j.issn.1008-0848.2011.08.006

2011-01-01

Abstract:Objective To investigate occurrence of erectile dysfunction (ED) in patients with pelvic fracture urethral distraction defects (PF UDD) who underwent urethroplasty, and the efficacy of sildenafil citrate in treatment of these patients. Methods Erectile function of 41 patients with urethral stricture who suffered from PF UDD were assessed by IIEF-5. Assessments were made at 4 time points including at the time of prior to inj ury, two weeks after urethroplasty, and three months post-treatment with sildenafil. Pharmacopenile duplex ultrasonography (PPUD) was used to examine blood flow of the cavernosum for differential diagnosis of arterial erectile dysfunction (ED), venous ED and non-vascular ED. All patients were treated with oral sildenafil, 100 mg once daily, three times a week, for three months. Results The incidence of ED following injury was 95.12%. There were significant differences in the IIEF-5 scores pre and post injury. There were no significant changes in scores following surgery. It suggested that stricture location has no obvious influence on the severity of ED post-urethroplasty and that is, the longer the stricture the lower the score, these di erences did not reach statistical signiicance Sildenail had a success rate of approximately 81%, which might be independent of age. Drug treatment seemed most effective for those with less severe ED at the outset. There was no significant difference in scores post-treatment between those who had vascular or non-vascular ED. The incidence of total side effects due to sildenafil was 19. 5%. Conclusion Urethral trauma is frequently associated with ED. Sildenafil citrate is useful drug for treatment of ED in these patients and appears to be well tolerated.